NMR solution structure of triazole bridged matriptase inhibitor
ID | Type | Value order | Atom ID 1 | Atom ID 2 |
---|---|---|---|---|
1 | covalent | sing | 1:ALA3:CB | 2:WMH1:C |
2 | covalent | sing | 1:ALA11:CB | 2:WMH1:C1 |
3 | covalent | sing | 1:GLY1:N | 1:ASP14:C |
Polymer type: polypeptide(L)
Total | 1H | 13C | 15N | |
---|---|---|---|---|
All | 88.7 % (142 of 160) | 98.8 % (85 of 86) | 73.0 % (46 of 63) | 100.0 % (11 of 11) |
Backbone | 82.1 % (64 of 78) | 100.0 % (26 of 26) | 65.9 % (27 of 41) | 100.0 % (11 of 11) |
Sidechain | 95.8 % (91 of 95) | 98.3 % (59 of 60) | 91.4 % (32 of 35) | |
Aromatic | 60.0 % (6 of 10) | 80.0 % (4 of 5) | 40.0 % (2 of 5) | |
Methyl | 100.0 % (10 of 10) | 100.0 % (5 of 5) | 100.0 % (5 of 5) |
1. entity 1
GRATKSIPPR AFPDSolvent system 90% H2O/10% D2O, Pressure 1 Pa, Temperature 298 K, pH 3.5, Details 1.5 mM DR12, 90% H2O/10% D2O
# | Name | Isotope labeling | Type | Concentration |
---|---|---|---|---|
1 | DR12 | natural abundance | 1.5 (±0.2) mM |